BRAF and melanoma: Heat inactivation reversed the direct neutrophil-mediated killing, but the neutrophils remained unable to increase the melanoma cell viability upon exposure to both BRAF/MEK inhibition and cisplatin, rendering protection an active process requiring intact neutrophils with unperturbed cellular content.